Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd Hong Kong S.E.
Equities
3347
CNE1000040M1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.1 HKD | -3.44% | -3.70% | -0.71% |
25/04 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
25/04 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.29% | 4 M€ | -27.92% | ||
0.59% | 2 M€ | -12.23% | - | |
0.07% | 2 M€ | -.--% | ||
0.03% | 7 M€ | -.--% | - | |
0.03% | 35 M€ | -5.85% | - | |
0.02% | 112 M€ | +5.41% | - | |
0.01% | 454 M€ | +9.82% | - | |
0.01% | 153 M€ | +9.25% | - | |
0.01% | 2,867 M€ | +11.35% | - | |
0.01% | 45 M€ | 0.00% | - | |
0.01% | 32 M€ | +9.08% | - | |
0.00% | 7 M€ | +6.58% | - | |
0.00% | 391 M€ | +9.28% | - | |
0.00% | 105 M€ | +4.03% | - | |
0.00% | 34 M€ | +3.87% | - | |
0.00% | 15 M€ | +18.83% | ||
0.00% | 54 M€ | +1.01% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- 300347 Stock
- 3347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd